Cartesian Therapeutics, Inc. RNAC
6.88 USD -0.01 (-0.15%)
At closeNov 11, 2026, 4:00 PM EST
6.88 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
6.70 Day range 7.09
5.60 52-week range 11.00
- YTD
- -4.58%
- 1 year
- -5.75%
RNAC revenue history
Revenue is income from the company’s ordinary business activities.
2,797,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 2,797,000 | -36,116,000 | -92.81% |
| FY 2024 | 2024-12-31 | 38,913,000 | 12,909,000 | 49.64% |
| FY 2023 | 2023-12-31 | 26,004,000 | -84,773,000 | -76.53% |
| FY 2022 | 2022-12-31 | 110,777,000 | 25,700,000 | 30.21% |
| FY 2021 | 2021-12-31 | 85,077,000 | 68,480,000 | 412.60% |
| FY 2020 | 2020-12-31 | 16,597,000 | 9,920,000 | 148.57% |
| FY 2019 | 2019-12-31 | 6,677,000 | 5,774,000 | 639.42% |
| FY 2018 | 2018-12-31 | 903,000 | 696,000 | 336.23% |
| FY 2017 | 2017-12-31 | 207,000 | -7,876,000 | -97.44% |
| FY 2016 | 2016-12-31 | 8,083,000 | 2,072,000 | 34.47% |
| FY 2015 | 2015-12-31 | 6,011,000 | 2,971,000 | 97.73% |
| FY 2014 | 2014-12-31 | 3,040,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-05T11:05:01.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.